165 related articles for article (PubMed ID: 28558783)
1. Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.
Volkow P; Cesarman-Maus G; Garciadiego-Fossas P; Rojas-Marin E; Cornejo-Juárez P
AIDS Res Ther; 2017 May; 14(1):30. PubMed ID: 28558783
[TBL] [Abstract][Full Text] [Related]
2. Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy.
Nyirenda M; Ngongondo M; Kang M; Umbleja T; Krown SE; Godfrey C; Samaneka W; Mngqibisa R; Hoagland B; Mwelase N; Caruso S; Martinez-Maza O; Dittmer DP; Borok M; Hosseinipour MC; Campbell TB;
J Acquir Immune Defic Syndr; 2020 Aug; 84(4):422-429. PubMed ID: 32265361
[TBL] [Abstract][Full Text] [Related]
3. As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.
Hosseinipour MC; Kang M; Krown SE; Bukuru A; Umbleja T; Martin JN; Orem J; Godfrey C; Hoagland B; Mwelase N; Langat D; Nyirenda M; MacRae J; Borok M; Samaneka W; Moses A; Mngqbisa R; Busakhala N; Martínez-Maza O; Ambinder R; Dittmer DP; Nokta M; Campbell TB;
Clin Infect Dis; 2018 Jul; 67(2):251-260. PubMed ID: 29365083
[TBL] [Abstract][Full Text] [Related]
4. Chylous ascites in disseminated Kaposi sarcoma: an unusual manifestation as immune reconstitution inflammatory syndrome.
Cipriano P; Nabais I; Melo N; Alves AR
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30904896
[TBL] [Abstract][Full Text] [Related]
5. Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.
Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
Clin Infect Dis; 2016 Nov; 63(10):1373-1379. PubMed ID: 27535953
[TBL] [Abstract][Full Text] [Related]
6. Kaposi sarcoma-induced immune reconstitution syndrome: a case report.
Abdeljaleel F; Azar J; Ayasa LA; Rabaia D
Ann Med Surg (Lond); 2024 Apr; 86(4):2242-2247. PubMed ID: 38576974
[TBL] [Abstract][Full Text] [Related]
7. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
; Rohner E; Schmidlin K; Zwahlen M; Chakraborty R; Clifford G; Obel N; Grabar S; Verbon A; Noguera-Julian A; Collins IJ; Rojo P; Brockmeyer N; Campbell M; Chêne G; Prozesky H; Eley B; Stefan DC; Davidson A; Chimbetete C; Sawry S; Davies MA; Kariminia A; Vibol U; Sohn A; Egger M; Bohlius J
Clin Infect Dis; 2016 Nov; 63(9):1245-1253. PubMed ID: 27578823
[TBL] [Abstract][Full Text] [Related]
8. The immune pathogenesis of immune reconstitution inflammatory syndrome associated with highly active antiretroviral therapy in AIDS.
Zheng Y; Zhou H; He Y; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2014 Dec; 30(12):1197-202. PubMed ID: 25131160
[TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.
Müller M; Wandel S; Colebunders R; Attia S; Furrer H; Egger M;
Lancet Infect Dis; 2010 Apr; 10(4):251-61. PubMed ID: 20334848
[TBL] [Abstract][Full Text] [Related]
10. Complexity of
Xerri T; Borg J; Casha R; Fsadni C
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34479876
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of classic and HIV-viremic and aviremic AIDS Kaposi sarcoma.
Séverin D; Bessaoud F; Meftah N; Du Thanh A; Tretarre B; Guillot B; Makinson A
AIDS; 2021 Mar; 35(3):399-405. PubMed ID: 33181532
[TBL] [Abstract][Full Text] [Related]
12. Unmasked Kaposi and sarcoidosis immune reconstitution inflammatory syndrome in a patient with AIDS.
Salto JN; Volkow P; Herrera-Goepfert R; López-Garcia AI; Cortes-Garcia BY; García-Pérez FO; Arroyo-Hernandez M; Rivera-Rosales RM
AIDS; 2024 May; 38(6):933-934. PubMed ID: 38578965
[No Abstract] [Full Text] [Related]
13. A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma lesions: proliferative and inflammatory.
Moorad R; Kasonkanji E; Gumulira J; Gondwe Y; Dewey M; Pan Y; Peng A; Pluta LJ; Kudowa E; Nyasosela R; Tomoka T; Tweya H; Heller T; Gugsa S; Phiri S; Moore DT; Damania B; Painschab M; Hosseinipour MC; Dittmer DP
Int J Cancer; 2023 Dec; 153(12):2082-2092. PubMed ID: 37602960
[TBL] [Abstract][Full Text] [Related]
14. Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe Lymphopenia.
Sereti I; Sheikh V; Shaffer D; Phanuphak N; Gabriel E; Wang J; Nason MC; Roby G; Ngeno H; Kirui F; Pau A; Mican JM; Rupert A; Bishop R; Agan B; Chomchey N; Teeratakulpisarn N; Tansuphaswadikul S; Langat D; Kosgei J; French M; Ananworanich J; Sawe F
Clin Infect Dis; 2020 Jul; 71(3):652-660. PubMed ID: 31504347
[TBL] [Abstract][Full Text] [Related]
15. Compression Therapy for HIV-Associated Kaposi Sarcoma Leg Lymphedema: Results of the Kenyan Improvised Compression for Kaposi Sarcoma Randomized Controlled Trial.
Chang AY; Karwa R; Odhiambo H; Were P; Fletcher SL; Tonui EC; Kohn MA; Lee J; Chang D; Lensing S; Namaemba DF; Busakhala N; Kiprono SK; Maurer T; Goodrich S; Pastakia SD
JCO Glob Oncol; 2022 Jan; 8():e2100329. PubMed ID: 35025687
[TBL] [Abstract][Full Text] [Related]
16. Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study.
Akanbi MO; Bilaver LA; Achenbach C; Hirschhorn LR; Rivera AS; Adekolujo OS; Adekola KUA; Silas OA; Agaba PA; Agbaji O; Shehu NY; Sagay SA; Hou L; Murphy RL
BMC Cancer; 2023 Sep; 23(1):890. PubMed ID: 37735371
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.
Rajdev L; Jackie Wang CC; Joshi H; Lensing S; Lee J; Ramos JC; Baiocchi R; Ratner L; Rubinstein PG; Ambinder R; Henry D; Streicher H; Little RF; Chiao E; Dittmer DP; Einstein MH; Cesarman E; Mitsuyasu R; Sparano JA;
Cancer; 2024 Mar; 130(6):985-994. PubMed ID: 37962072
[TBL] [Abstract][Full Text] [Related]
18. Spurious Presentation of Pulmonary Kaposi Sarcoma as Unresolved Pneumonia Led to Fatal Outcome.
Mann BK; D'Assumpcao C; Okumoto L; Aboaid S; Abooed A; Cobos E; Heidari A
J Investig Med High Impact Case Rep; 2023; 11():23247096231208996. PubMed ID: 37919962
[TBL] [Abstract][Full Text] [Related]
19. A Challenging Case of Kaposi Sarcoma Inflammatory Cytokine Syndrome.
Al-Obaidi A; Mahadevia H; Syed Z; Raza S
Cureus; 2023 Jul; 15(7):e42218. PubMed ID: 37605703
[TBL] [Abstract][Full Text] [Related]
20. Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings.
Epeldegui M; Chang D; Lee J; Magpantay LI; Borok M; Bukuru A; Busakhala N; Godfrey C; Hosseinipour MC; Kang M; Kanyama C; Langat D; Mngqibisa R; Mwelase N; Nyirenda M; Samaneka W; Hoagland B; Campbell TB; Martínez-Maza O; Krown SE;
J Acquir Immune Defic Syndr; 2023 Oct; 94(2):165-173. PubMed ID: 37368929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
